Needham Reiterates Buy on Merit Medical Systems, Maintains $101 Price Target
Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $101 price target.
Stocks · News reference
BTIG analyst Sam Eiber reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $105 price target.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Needham analyst Mike Matson reiterates Merit Medical Systems (NASDAQ:MMSI) with a Buy and maintains $101 price target.
Filed: 2026-08-20 AccNo: 0000856982-26-000047 Size: 4 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Top analysts changed outlook on top names. Truist, Morgan Stanley, B of A Securities, HC Wainwright, Baird, and Stephens & Co. altered price targets for various stocks.
B of A Securities analyst Craig Bijou maintains Merit Medical Systems (NASDAQ:MMSI) with a Neutral and raises the price target from $92 to $97.